vs

Side-by-side financial comparison of Carter Bankshares, Inc. (CARE) and Valneva SE (VALN). Click either name above to swap in a different company.

Carter Bankshares, Inc. is the larger business by last-quarter revenue ($39.8M vs $36.2M, roughly 1.1× Valneva SE).

Carter Bankshares, Inc. is a U.S. regional bank holding company operating Carter Bank & Trust, a community-focused financial institution. It offers a full range of retail and commercial banking products including deposit accounts, personal and business loans, and wealth management services, primarily serving consumers and small business clients across Virginia and North Carolina.

Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States.

CARE vs VALN — Head-to-Head

Bigger by revenue
CARE
CARE
1.1× larger
CARE
$39.8M
$36.2M
VALN

Income Statement — Q4 FY2025 vs Q1 FY2023

Metric
CARE
CARE
VALN
VALN
Revenue
$39.8M
$36.2M
Net Profit
$-19.6M
Gross Margin
38.9%
Operating Margin
27.8%
-49.5%
Net Margin
-54.1%
Revenue YoY
15.4%
Net Profit YoY
EPS (diluted)
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CARE
CARE
VALN
VALN
Q4 25
$39.8M
Q3 25
$39.1M
Q2 25
$37.3M
Q1 25
$37.0M
Q4 24
$34.5M
Q3 24
$34.2M
Q2 24
$33.6M
Q1 24
$33.5M
Net Profit
CARE
CARE
VALN
VALN
Q4 25
Q3 25
$5.4M
Q2 25
$8.5M
Q1 25
$9.0M
Q4 24
Q3 24
$5.6M
Q2 24
$4.8M
Q1 24
$5.8M
Operating Margin
CARE
CARE
VALN
VALN
Q4 25
27.8%
Q3 25
18.3%
Q2 25
28.5%
Q1 25
30.1%
Q4 24
31.0%
Q3 24
20.5%
Q2 24
17.6%
Q1 24
21.6%
Net Margin
CARE
CARE
VALN
VALN
Q4 25
Q3 25
13.9%
Q2 25
22.8%
Q1 25
24.2%
Q4 24
Q3 24
16.4%
Q2 24
14.3%
Q1 24
17.4%
EPS (diluted)
CARE
CARE
VALN
VALN
Q4 25
$0.38
Q3 25
$0.24
Q2 25
$0.37
Q1 25
$0.39
Q4 24
$0.36
Q3 24
$0.24
Q2 24
$0.21
Q1 24
$0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CARE
CARE
VALN
VALN
Cash + ST InvestmentsLiquidity on hand
$274.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$419.7M
$221.2M
Total Assets
$4.9B
$637.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Stockholders' Equity
CARE
CARE
VALN
VALN
Q4 25
$419.7M
Q3 25
$412.8M
Q2 25
$405.6M
Q1 25
$401.8M
Q4 24
$384.3M
Q3 24
$386.8M
Q2 24
$364.4M
Q1 24
$359.1M
Total Assets
CARE
CARE
VALN
VALN
Q4 25
$4.9B
Q3 25
$4.8B
Q2 25
$4.8B
Q1 25
$4.7B
Q4 24
$4.7B
Q3 24
$4.6B
Q2 24
$4.5B
Q1 24
$4.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CARE
CARE
VALN
VALN
Operating Cash FlowLast quarter
$39.9M
$-26.3M
Free Cash FlowOCF − Capex
$31.8M
FCF MarginFCF / Revenue
79.9%
Capex IntensityCapex / Revenue
20.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$54.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CARE
CARE
VALN
VALN
Q4 25
$39.9M
Q3 25
$11.8M
Q2 25
$9.6M
Q1 25
$6.4M
Q4 24
$36.9M
Q3 24
$10.3M
Q2 24
$-2.5M
Q1 24
$17.6M
Free Cash Flow
CARE
CARE
VALN
VALN
Q4 25
$31.8M
Q3 25
$10.3M
Q2 25
$7.7M
Q1 25
$4.9M
Q4 24
$28.8M
Q3 24
$8.4M
Q2 24
$-4.3M
Q1 24
$16.3M
FCF Margin
CARE
CARE
VALN
VALN
Q4 25
79.9%
Q3 25
26.3%
Q2 25
20.6%
Q1 25
13.1%
Q4 24
83.5%
Q3 24
24.6%
Q2 24
-12.7%
Q1 24
48.8%
Capex Intensity
CARE
CARE
VALN
VALN
Q4 25
20.2%
Q3 25
3.9%
Q2 25
5.1%
Q1 25
4.1%
Q4 24
23.6%
Q3 24
5.5%
Q2 24
5.4%
Q1 24
3.9%
Cash Conversion
CARE
CARE
VALN
VALN
Q4 25
Q3 25
2.18×
Q2 25
1.13×
Q1 25
0.71×
Q4 24
Q3 24
1.83×
Q2 24
-0.51×
Q1 24
3.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons